Agree - but that myopic behavior isn’t really particularly helpful even in small research labs. It just gets less visibility. Interestingly biotech CEOs who’ve come from WS, or other areas where they see a LOT of biotechs from 50k ft, seem to have a higher hit rate?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.